Document Type
Fact Sheet
Publication Date
10-1-2024
Abstract
Leveraging our experience developing the monthly dapivirine vaginal ring (DVR or “PrEP ring”), which received a positive opinion from the European Medicines Agency in 2020 for women’s HIV risk reduction, the Population Council is developing a 3-month multipurpose vaginal ring to help women protect against both HIV and unintended pregnancy. This ring is designed to slowly release the antiretroviral (ARV) drug, dapivirine and the contraceptive hormone, levonorgestrel.
Recommended Citation
IPM South Africa. 2024. "Dapivirine Levonorgestrel Vaginal Ring: A multipurpose prevention ring for HIV and contraceptive protection," factsheet. Population Council.
Language
English
Project
The Dapivirine Vaginal Ring for HIV Prevention
COinS